NCT07117929

Brief Summary

The goal of this clinical trial is to learn if pulsed electromagnetic field (PEMF) combined with home exercise improves healing and function in adults with meniscus tears. The main questions it aims to answer are:

  • Be assigned randomly to either the PEMF group (active treatment) or the sham PEMF group (inactive, but identical in appearance)
  • Receive either real PEMF therapy or sham treatment twice a week for 8 weeks (each session lasts 10 minutes).
  • Follow a standard home exercise program to strengthen their knees.
  • Have their knee function, pain levels, and healing progress checked through MRI scans, questionnaires, imaging and physical tests.
  • Return for 3 follow-up visits after the 8-week treatment period.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
15mo left

Started Aug 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress37%
Aug 2025Aug 2027

First Submitted

Initial submission to the registry

July 28, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 12, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

August 15, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

August 12, 2025

Status Verified

August 1, 2025

Enrollment Period

1.5 years

First QC Date

July 28, 2025

Last Update Submit

August 5, 2025

Conditions

Keywords

meniscal injuriesmeniscus tearmeniscal injury

Outcome Measures

Primary Outcomes (1)

  • Between-group difference in mean change of intrameniscal fluid-equivalent signal area at 6 months post-intervention, as assessed by MRI.

    A musculoskeletal radiologist, blinded to the participants' group assignments and clinical details, will perform these assessments using fat- suppressed T2-weighted imaging. The primary imaging endpoint will be the between-group difference in the mean change of the intrameniscal fluid-equivalent signal area (mm2) from baseline to 6 months. The fluid-equivalent signal area will be delineated and quantified using standardized region-of-interest (ROI) methods on consecutive slices encompassing the original tear site.

    Baseline to 6 months post intervention

Secondary Outcomes (15)

  • Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) Scores for Pain, Symptoms, Activities of Daily Living, Sport/Recreation Function, and Knee-Related Quality of Life

    Baseline to 1-, 2-, 6-, and 12-months post intervention

  • Change in Western Ontario Meniscal Evaluation Tool (WOMET) Scores for Physical Symptoms, Sports/Work/Lifestyle, and Emotional Domains

    Baseline, 1, 2, 6, and 12 months post-intervention

  • Change from Baseline in Active Knee Range of Motion at 12 Month

    Baseline, weekly during the 8-week intervention, and at 2-, 6-, and 12-months post commencement of intervention.

  • Change from Baseline in Passive Knee Range of Motion at 12 Month

    Baseline, weekly during the 8-week intervention, and at 2-, 6-, and 12-months post commencement of intervention

  • Change from Baseline in 60-Second Sit-to-Stand Test Score (Number of Repetitions) at 12 Months

    Baseline, weekly during the 8-week intervention, and at 2-, 6-, and 12-months post commencement of intervention.

  • +10 more secondary outcomes

Study Arms (2)

PEMF Group

ACTIVE COMPARATOR

1. PEMF Therapy: Participants will undergo active PEMF therapy sessions lasting 10 minutes each, conducted twice weekly for 16 sessions, with a specified PEMF device (QuantumTX Pte Ltd, Singapore). 2. Exercise Therapy: All participants will be provided with the same standardised home exercise protocol.

Device: Active PEMFOther: Exercise

Control Group

SHAM COMPARATOR

1. Sham PEMF Therapy: Participants will undergo sham PEMF therapy sessions lasting 10 minutes each, conducted twice weekly for 16 sessions, with a specified PEMF device (QuantumTX Pte Ltd, Singapore). 2. Exercise Therapy: All participants will be provided with the same standardised home exercise protocol.

Device: Sham PEMFOther: Exercise

Interventions

PEMF: 1.5mT, 10Hz, 10 minutes

PEMF Group
Sham PEMFDEVICE

PEMF 0mT, 0Hz, 10 minutes

Control Group

Standardised home exercise protocol

Control GroupPEMF Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Male and female patients aged 18-60
  • Clinical history, signs, and symptoms indicative of a meniscal tear
  • MRI confirmation of a non-displaced, and unilateral meniscal tear
  • Meniscal tears located within red-white and white-white zones
  • Willingness to adhere to a 8-week regimen of PEMF and exercise therapy
  • Ability to provide written informed consent

You may not qualify if:

  • Congenital discoid meniscus confirmed by MRI
  • Complex, oblique, flap, or displaced bucket handle tears confirmed by MRI
  • Meniscal root tears confirmed by MRI
  • Evidence of partial healing on baseline MRI
  • Presence of mechanical symptoms (e.g., locking or catching)
  • Acute onset exacerbation of knee symptoms (e.g., severe pain or swelling)
  • Surgical intervention during the therapy session
  • Knee axis deformities that necessitate surgical correction
  • Prior surgery or fracture in the affected limb within the past 12 months
  • Severe radiographic knee OA (Kellgren-Lawrence scale ≥2)
  • Implanted electronic medical devices (e.g., pacemakers or cochlear implants) • Current pregnancy or intention to become pregnant during the study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Room 124007, 10/F, Lui Chi Woo Clinical Sciences Building, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China

Hong Kong, Hong Kong

Location

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chairman, Department of Orthopaedics & Traumatology, Faculty of Medicine, The Chinese University of Hong Kong

Study Record Dates

First Submitted

July 28, 2025

First Posted

August 12, 2025

Study Start

August 15, 2025

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

August 1, 2027

Last Updated

August 12, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Starting 6 months after publication

Locations